The role of dendritic cells in autoimmunity

Nature Reviews Immunology

Volumn 13, Issue 8, 2013, Pages 566-577

  Ganguly, Dipyaman ^a,b   Haak, Stefan ^a,c   Sisirak, Vanja ^a   Reizis, Boris ^a  

^a NewYork Presbyterian Hospital   (United States)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; AUTOIMMUNE MYOCARDITIS; AUTOIMMUNITY; DENDRITIC CELL; GENE TARGETING; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMOCYTE;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNITY; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNITY, INNATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MULTIPLE SCLEROSIS; MYOCARDITIS; PSORIASIS; RATS; SELF TOLERANCE;

EID: 84880924243     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3477     Document Type: Review

References (118)

1. Steinman, R. M. Decisions about dendritic cells: past, present, and future. Annu. Rev. Immunol. 30, 1-22 (2012).
2. Hashimoto, D., Miller, J. & Merad, M. Dendritic cell and macrophage heterogeneity in vivo. Immunity 35, 323-335 (2011).
3. Satpathy, A. T., Wu, X., Albring, J. C. & Murphy, K. M. Re(de)fining the dendritic cell lineage. Nature Immunol. 13, 1145-1154 (2012).
4. Lewis, K. L. & Reizis, B. Dendritic cells: arbiters of immunity and immunological tolerance. Cold Spring Harb. Perspect. Biol. 4, a007401 (2012).
5. Collin, M., Bigley, V., Haniffa, M. & Hambleton, S. Human dendritic cell deficiency: the missing ID? Nature Rev. Immunol. 11, 575-583 (2011).
6. Segura, E. et al. Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 38, 336-348 (2013).
7. Segura, E. et al. Characterization of resident and migratory dendritic cells in human lymph nodes. J. Exp. Med. 209, 653-660 (2012).
8. Olsson, T., Holmdahl, R., Klareskog, L. & Forsum, U. Ia-expressing cells and T lymphocytes of different subsets in peripheral nerve tissue during experimental allergic neuritis in Lewis rats. Scand. J. Immunol. 18, 339-343 (1983). (Pubitemid 14240188)
9. Knight, S. C., Mertin, J., Stackpoole, A. & Clark, J. Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. Proc. Natl Acad. Sci. USA 80, 6032-6035 (1983). This paper shows that 'veiled cells' (that is, DCs) from animals with EAE could transfer the disease to naive recipients, which establishes the capacity of DCs to prime autoreactive T cell responses. (Pubitemid 14228238)
10. Gallegos, A. M. & Bevan, M. J. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J. Exp. Med. 200, 1039-1049 (2004). (Pubitemid 39431128)
11. Hubert, F. X. et al. Aire regulates the transfer of antigen from mTECs to dendritic cells for induction of thymic tolerance. Blood 118, 2462-2472 (2011).
12. Lei, Y. et al. Aire-dependent production of XCL1 mediates medullary accumulation of thymic dendritic cells and contributes to regulatory T cell development. J. Exp. Med. 208, 383-394 (2011).
13. Klein, L., Hinterberger, M., von Rohrscheidt, J. & Aichinger, M. Autonomous versus dendritic cell-dependent contributions of medullary thymic epithelial cells to central tolerance. Trends Immunol. 32, 188-193 (2011).
14. Birnberg, T. et al. Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome. Immunity 29, 986-997 (2008). This paper shows that the constitutive ablation of cDCs does not breach central or peripheral tolerance or induce overt autoimmunity.
15. Bonasio, R. et al. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nature Immunol. 7, 1092-1100 (2006). (Pubitemid 44420654)
16. Proietto, A. I. et al. Dendritic cells in the thymus contribute to T-regulatory cell induction. Proc. Natl Acad. Sci. USA 105, 19869-19874 (2008).
17. Hawiger, D. et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769-779 (2001). This study pioneered antibody-mediated antigen targeting to demonstrate the capacity of DCs to induce peripheral T cell tolerance. (Pubitemid 32983013)
18. Hawiger, D., Masilamani, R. F., Bettelli, E., Kuchroo, V. K. & Nussenzweig, M. C. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity 20, 695-705 (2004). (Pubitemid 38757440)
19. Probst, H. C., Lagnel, J., Kollias, G. & van den Broek, M. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity 18, 713-720 (2003). This paper further shows the tolerogenic capacity of DCs in the steady state by genetically targeting antigens to DCs. (Pubitemid 36588587)
20. Probst, H. C., McCoy, K., Okazaki, T., Honjo, T. & van den Broek, M. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nature Immunol. 6, 280-286 (2005). (Pubitemid 41724765)
21. Muth, S., Schutze, K., Schild, H. & Probst, H. C. Release of dendritic cells from cognate CD4+ T-cell recognition results in impaired peripheral tolerance and fatal cytotoxic T-cell mediated autoimmunity. Proc. Natl Acad. Sci. USA 109, 9059-9064 (2012).
22. Yamazaki, S. et al. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198, 235-247 (2003). (Pubitemid 37009740)
23. Sela, U., Olds, P., Park, A., Schlesinger, S. J. & Steinman, R. M. Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice. J. Exp. Med. 208, 2489-2496 (2011).
24. Suffner, J. et al. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice. J. Immunol. 184, 1810-1820 (2010).
25. Bar-On, L., Birnberg, T., Kim, K. W. & Jung, S. Dendritic cell-restricted CD80/86 deficiency results in peripheral regulatory T-cell reduction but is not associated with lymphocyte hyperactivation. Eur. J. Immunol. 41, 291-298 (2011).
26. Vitali, C. et al. Migratory, and not lymphoid-resident, dendritic cells maintain peripheral self-tolerance and prevent autoimmunity via induction of iTreg cells. Blood 120, 1237-1245 (2012).
27. Darrasse-Jeze, G. et al. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 206, 1853-1862 (2009).
28. Swee, L. K., Bosco, N., Malissen, B., Ceredig, R. & Rolink, A. Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatment. Blood 113, 6277-6287 (2009).
29. Collins, C. B. et al. Flt3 ligand expands CD103+ dendritic cells and FoxP3+ T regulatory cells, and attenuates Crohn's-like murine ileitis. Gut 61, 1154-1162 (2011).
30. Kriegel, M. A., Rathinam, C. & Flavell, R. A. Pancreatic islet expression of chemokine CCL2 suppresses autoimmune diabetes via tolerogenic CD11c+ CD11b+ dendritic cells. Proc. Natl Acad. Sci. USA 109, 3457-3462 (2012).
31. Edelson, B. T. et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells. J. Exp. Med. 207, 823-836 (2010).
32. Lewis, K. L. et al. Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine. Immunity 35, 780-791 (2011).
33. Zangi, L. et al. Deletion of cognate CD8 T cells by immature dendritic cells: a novel role for perforin, granzyme A, TREM-1, and TLR7. Blood 120, 1647-1657 (2012).
34. Ohnmacht, C. et al. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 206, 549-559 (2009).
35. Teichmann, L. L. et al. Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage. Immunity 33, 967-978 (2010).
36. Cervantes-Barragan, L. et al. Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc. Natl Acad. Sci. USA 109, 3012-3017 (2012).
37. Chen, M. et al. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311, 1160-1164 (2006).
38. Stranges, P. B. et al. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 26, 629-641 (2007). (Pubitemid 46756349)
39. Chen, M., Felix, K. & Wang, J. Immune regulation through mitochondrion-dependent dendritic cell death induced by T regulatory cells. J. Immunol. 187, 5684-5692 (2011).
40. Travis, M. A. et al. Loss of integrin αvβ8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449, 361-365 (2007). (Pubitemid 47443473)
41. Melillo, J. A. et al. Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function. J. Immunol. 184, 2638-2645 (2010).
42. Kim, S. J., Zou, Y. R., Goldstein, J., Reizis, B. & Diamond, B. Tolerogenic function of Blimp-1 in dendritic cells. J. Exp. Med. 208, 2193-2199 (2011).
43. Hammer, G. E. et al. Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nature Immunol. 12, 1184-1193 (2011).
44. Kool, M. et al. The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity. Immunity 35, 82-96 (2011).
45. Kaneko, T. et al. Dendritic cell-specific ablation of the protein tyrosine phosphatase Shp1 promotes Th1 cell differentiation and induces autoimmunity. J. Immunol. 188, 5397-5407 (2012).
46. Abram, C. L., Roberge, G. L., Pao, L. I., Neel, B. G. & Lowell, C. A. Distinct roles for neutrophils and dendritic cells in inflammation and autoimmunity in motheaten mice. Immunity 38, 489-501 (2013).
47. Eriksson, U. et al. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nature Med. 9, 1484-1490 (2003). (Pubitemid 38004775)
48. Eriksson, U. et al. Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis. J. Exp. Med. 197, 323-331 (2003). (Pubitemid 36184239)
49. Sonderegger, I. et al. GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J. Exp. Med. 205, 2281-2294 (2008).
50. Pagni, P. P., Traub, S., Demaria, O., Chasson, L. & Alexopoulou, L. Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient mice to myocarditis. Autoimmunity 43, 275-287 (2010).
51. Popovic, Z. V. et al. The proteoglycan biglycan enhances antigen-specific T cell activation potentially via MyD88 and TRIF pathways and triggers autoimmune perimyocarditis. J. Immunol. 187, 6217-6226 (2011).
52. McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H. & Miller, S. D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nature Med. 11, 335-339 (2005). (Pubitemid 40460563)
53. Greter, M. et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nature Med. 11, 328-334 (2005). (Pubitemid 40460562)
54. Wu, G. F. et al. Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity. J. Autoimmun. 36, 56-64 (2011).
55. Yogev, N. et al. Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor+ regulatory T cells. Immunity 37, 264-275 (2012). This paper shows the overall anti-inflammatory role of cDCs in EAE using various DC ablation methods.
56. Isaksson, M., Lundgren, B. A., Ahlgren, K. M., Kampe, O. & Lobell, A. Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE. Eur. J. Immunol. 42, 2555-2563 (2012).
57. Huang, G. et al. Signaling via the kinase p38α programs dendritic cells to drive TH17 differentiation and autoimmune inflammation. Nature Immunol. 13, 152-161 (2012).
58. Melton, A. C. et al. Expression of αvβ8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice. J. Clin. Invest. 120, 4436-4444 (2010).
59. Laouar, Y. et al. TGF-β signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 105, 10865-10870 (2008).
60. Xiao, S. et al. Tim-1 stimulation of dendritic cells regulates the balance between effector and regulatory T cells. Eur. J. Immunol. 41, 1539-1549 (2011).
61. Guo, B., Chang, E. Y. & Cheng, G. The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J. Clin. Invest. 118, 1680-1690 (2008). (Pubitemid 351632372)
62. Dann, A. et al. Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS. Nature Neurosci. 15, 98-106 (2012).
63. Yen, J. H., Kong, W. & Ganea, D. IFN-β inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9. J. Immunol. 184, 3478-3486 (2010).
64. Anandasabapathy, N. et al. Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain. J. Exp. Med. 208, 1695-1705 (2011).
65. Prodinger, C. et al. CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system. Acta Neuropathol. 121, 445-458 (2011).
66. Bailey, S. L., Schreiner, B., McMahon, E. J. & Miller, S. D. CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE. Nature Immunol. 8, 172-180 (2007). (Pubitemid 46152648)
67. Poppensieker, K. et al. CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells. Proc. Natl Acad. Sci. USA 109, 3897-3902 (2012).
68. Codarri, L. et al. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nature Immunol. 12, 560-567 (2011).
69. El-Behi, M. et al. The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nature Immunol. 12, 568-575 (2011).
70. Bailey-Bucktrout, S. L. et al. Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J. Immunol. 180, 6457-6461 (2008).
71. Irla, M. et al. MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity. J. Exp. Med. 207, 1891-1905 (2010). Genetic ablation of MHC class II expression specifically in pDCs shows that pDCs might promote TReg cell development and they might inhibit inflammation in EAE.
72. Karni, A. et al. Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. J. Immunol. 177, 4196-4202 (2006). (Pubitemid 44359955)
73. Cai, Y. et al. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity 35, 596-610 (2011).
74. Pantelyushin, S. et al. Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice. J. Clin. Invest. 122, 2252-2256 (2012).
75. van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 182, 5836-5845 (2009).
76. Walter, A. et al. Aldara activates TLR7-independent immune defence. Nature Commun. 4, 1560 (2013).
77. Tortola, L. et al. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J. Clin. Invest. 122, 3965-3976 (2012).
78. Nestle, F. O. et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. J. Exp. Med. 202, 135-143 (2005). (Pubitemid 41002916)
79. Albanesi, C. et al. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J. Exp. Med. 206, 249-258 (2009).
80. Guiducci, C. et al. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9. J. Exp. Med. 207, 2931-2942 (2010).
81. Gregorio, J. et al. Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. J. Exp. Med. 207, 2921-2930 (2010).
82. Lande, R. et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564-569 (2007). (Pubitemid 47525141)
83. Ganguly, D. et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 206, 1983-1994 (2009).
84. de Jersey, J. et al. β-cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice. Proc. Natl Acad. Sci. USA 104, 1295-1300 (2007). (Pubitemid 46183998)
85. Turley, S., Poirot, L., Hattori, M., Benoist, C. & Mathis, D. Physiological β-cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J. Exp. Med. 198, 1527-1537 (2003). This paper established the role of DCs in the presentation of β-islet cell antigens to self-reactive T cells in experimental diabetes. (Pubitemid 37467167)
86. Saxena, V., Ondr, J. K., Magnusen, A. F., Munn, D. H. & Katz, J. D. The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. J. Immunol. 179, 5041-5053 (2007).
87. Calderon, B., Suri, A., Miller, M. J. & Unanue, E. R. Dendritic cells in islets of Langerhans constitutively present β-cell-derived peptides bound to their class II MHC molecules. Proc. Natl Acad. Sci. USA 105, 6121-6126 (2008). (Pubitemid 351758409)
88. Han, J. et al. Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice. Diabetes 57, 2118-2127 (2008).
89. Kim, H. S. et al. Toll-like receptor 2 senses β-cell death and contributes to the initiation of autoimmune diabetes. Immunity 27, 321-333 (2007). (Pubitemid 47284922)
90. Lee, L. F. et al. The role of TNF-α in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation. Proc. Natl Acad. Sci. USA 102, 15995-16000 (2005).
91. Van Belle, T. L., Nierkens, S., Arens, R. & von Herrath, M. G. Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets. Immunity 36, 1060-1072 (2012).
92. Huang, X., Hultgren, B., Dybdal, N. & Stewart, T. A. Islet expression of interferon-α precedes diabetes in both the BB rat and streptozotocin-treated mice. Immunity 1, 469-478 (1994).
93. Huang, X. et al. Interferon expression in the pancreases of patients with type I diabetes. Diabetes 44, 658-664 (1995).
94. Li, Q. et al. Interferon-α initiates type 1 diabetes in nonobese diabetic mice. Proc. Natl Acad. Sci. USA 105, 12439-12444 (2008).
95. Diana, J. et al. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nature Med. 19, 65-73 (2013).
96. Allen, J. S. et al. Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture. Diabetes 58, 138-145 (2009).
97. Chilton, P. M. et al. Flt3-ligand treatment prevents diabetes in NOD mice. Diabetes 53, 1995-2002 (2004). (Pubitemid 38970747)
98. O'Keeffe, M. et al. Fms-like tyrosine kinase 3 ligand administration overcomes a genetically determined dendritic cell deficiency in NOD mice and protects against diabetes development. Int. Immunol. 17, 307-314 (2005).
99. Kared, H. et al. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4+CD25+ regulatory T-cells. Diabetes 54, 78-84 (2005). (Pubitemid 40105097)
100. Grupillo, M. et al. Essential roles of insulin expression in Aire+ tolerogenic dendritic cells in maintaining peripheral self-tolerance of islet β-cells. Cell. Immunol. 273, 115-123 (2012).
101. Walsh, E. R. et al. Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity. Proc. Natl Acad. Sci. USA 109, 16276-16281 (2012).
102. Bennett, L. et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197, 711-723 (2003). (Pubitemid 36350866)
103. Santiago-Raber, M. L. et al. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J. Exp. Med. 197, 777-788 (2003).
104. Jorgensen, T. N., Roper, E., Thurman, J. M., Marrack, P. & Kotzin, B. L. Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice. Genes Immun. 8, 653-662 (2007). (Pubitemid 350238435)
105. Ronnblom, L. & Alm, G. V. A pivotal role for the natural interferon-α-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J. Exp. Med. 194, F59-F63 (2001). (Pubitemid 34028649)
106. Blomberg, S. et al. Presence of cutaneous interferon-α producing cells in patients with systemic lupus erythematosus. Lupus 10, 484-490 (2001). (Pubitemid 32675048)
107. Bave, U. et al. Fcγ RIIa is expressed on natural IFN-α-producing cells (plasmacytoid dendritic cells) and is required for the IFN-α production induced by apoptotic cells combined with lupus IgG. J. Immunol. 171, 3296-3302 (2003). (Pubitemid 37093557)
108. Means, T. K. et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115, 407-417 (2005). (Pubitemid 40385482)
109. Tian, J. et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nature Immunol. 8, 487-496 (2007). (Pubitemid 46605917)
110. Lande, R. et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra19 (2011).
111. Garcia-Romo, G. S. et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra20 (2011). References 110 and 111 provide evidence that pDC activation by neutrophil-derived self-DNA molecules promotes the development of SLE in humans.
112. Guiducci, C. et al. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature 465, 937-941 (2010).
113. Lepelletier, Y. et al. Toll-like receptor control of glucocorticoid- induced apoptosis in human plasmacytoid predendritic cells (pDCs). Blood 116, 3389-3397 (2010).
114. Zhu, X. J., Yang, Z. F., Chen, Y., Wang, J. & Rosmarin, A. G. PU.1 is essential for CD11c expression in CD8+/CD8- lymphoid and monocyte-derived dendritic cells during GM-CSF or FLT3L-induced differentiation. PLoS ONE 7, e52141 (2013).
115. Caton, M. L., Smith-Raska, M. R. & Reizis, B. Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J. Exp. Med. 204, 1653-1664 (2007). (Pubitemid 47048031)
116. Persson, E. K. et al. IRF4 transcription-factor-dependent CD103+CD11b+ dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 38, 958-969 (2013).
117. Schlitzer, A. et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38, 970-983 (2013).
118. Wohn, C. et al. Langerinneg conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice. Proc. Natl Acad. Sci. USA 110, 10723-10728 (2013).